abrocitinib 100 MG Oral Tablet

RxCUI: 2591481
RxNorm name: abrocitinib 100 MG Oral Tablet
Display name: abrocitinib 100 MG Oral Tablet
Full name: abrocitinib 100 MG Oral Tablet
Term type: PSN
Status: DailyMed mapping
Updated: 2026-06-04 23:38:55

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
CIBINQO	ABROCITINIB	U.S. Pharmaceuticals	16c12a56-4550-414b-ac9d-b785b41fea6b	2026-07-09	Boxed warning, Warnings, Adverse reactions	Exact identifier rxcui: 2591481
Cibinqo	ABROCITINIB	Pfizer Laboratories Div Pfizer Inc	3f6d6fcd-e9f9-42c8-bfa2-bb2cfc9ed258	2026-07-07	Boxed warning, Warnings, Adverse reactions	Exact identifier rxcui: 2591481

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set ID	RxNorm string	TTY	SPL version	Label	Effective
3f6d6fcd-e9f9-42c8-bfa2-bb2cfc9ed258	abrocitinib 100 MG Oral Tablet	PSN	6	These highlights do not include all the information needed to use CIBINQO safely and effectively. See full prescribing information for CIBINQO. CIBINQO ® (abrocitinib) tablets, for oral use Initial U.S. Approval: 2022	20250109
3f6d6fcd-e9f9-42c8-bfa2-bb2cfc9ed258	abrocitinib 100 MG Oral Tablet	SCD	6	These highlights do not include all the information needed to use CIBINQO safely and effectively. See full prescribing information for CIBINQO. CIBINQO ® (abrocitinib) tablets, for oral use Initial U.S. Approval: 2022	20250109
16c12a56-4550-414b-ac9d-b785b41fea6b	abrocitinib 100 MG Oral Tablet	PSN	4	These highlights do not include all the information needed to use CIBINQO safely and effectively. See full prescribing information for CIBINQO. CIBINQO ® (abrocitinib) tablets, for oral use Initial U.S. Approval: 2022	20250320
16c12a56-4550-414b-ac9d-b785b41fea6b	abrocitinib 100 MG Oral Tablet	SCD	4	These highlights do not include all the information needed to use CIBINQO safely and effectively. See full prescribing information for CIBINQO. CIBINQO ® (abrocitinib) tablets, for oral use Initial U.S. Approval: 2022	20250320